Showing results (141-150 of 1,250) with videos related to
Sort By:
Pageof 125
Journal of Neural Transmission (Vienna, Austria : 1996)|March 17, 2017
Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson's diseaseThomas Müller, Peter Riederer, Edna GrünblattExpert Review of Clinical Pharmacology|February 2, 2023
Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome?Thomas Müller, Peter Riederer, Wilfried KuhnTrends in Parasitology|February 11, 2025
Subcellular dynamics in unicellular parasitesThomas Müller, Timothy Krüger, Markus EngstlerTraffic Injury Prevention|October 31, 2019
Effect of the Q10 dummy upgrade kit in UN Regulation No. 129 front and side impact testsCostandinos Visvikis, Christoph Thurn, Thomas MüllerParkinsonism & Related Disorders|December 11, 2002
Neuroleptic malignant-like syndrome after rapid switch from bromocriptine to pergolideJens Reimer, Anita Kuhlmann, Thomas MüllerAccounts of Chemical Research|February 8, 2020
Trialkylsilyl-Substituted Silole and Germole Dianions as Precursors for Unusual Silicon and Germanium CompoundsZhaowen Dong, Lena Albers, Thomas MüllerJournal of Neural Transmission (Vienna, Austria : 1996)|January 11, 2020
Kinesiology training in patients with Parkinson's disease: results of a pilot studyWilfried Kuhn, Tanja Neufeld, Thomas MüllerJournal of the American Chemical Society|July 27, 2006
Hydrogen- and fluorine-bridged disilyl cations and their use in catalytic C-F activationRobin Panisch, Michael Bolte, Thomas MüllerClinical Neuropharmacology|July 7, 2017
Determination of Monoamine Oxidase A and B Activity in Long-Term Treated Patients With Parkinson DiseaseThomas Müller, Peter Riederer, Edna GrünblattHandbook of Experimental Pharmacology|December 12, 2007
TLR9-mediated recognition of DNAThomas Müller, Svetlana Hamm, Stefan BauerPageof 125